Compare Centene Corp (CNC) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Visa Inc — how do they compare? Centene Corp trades at $66 (market cap $33.93B), while Visa Inc trades at $352.56 (market cap $677.06B). The key difference: Visa Inc is far larger — about 20× Centene Corp's market cap, and Visa Inc pays a 0.75% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | V | |
|---|---|---|
Market Cap | $33.93B | $677.06B |
Sector | Health | Financials |
52-Week High | $68.72 | $362.13 |
52-Week Low | $25.21 | $295.52 |
Enterprise Value | $26.56B | $687.65B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
Visa (V) trades at $355.01, down 0.77% on the day, but maintains strong technical momentum with bullish moving averages and key support at $354. The company demonstrates robust fundamentals with consistent earnings beats, 51.68% net income margins, and 16.28% ROE. Recent developments include the launch of Intelligent Commerce Connect for AI-driven commerce and stablecoin partnerships, positioning Visa at the forefront of payment innovation.
Visa presents a compelling long-term investment with 85% analyst buy ratings and a $394.50 consensus price target implying 11% upside. Risks include fintech disruption and regulatory pressures, but the company's dominant market position, expanding revenue base, and strong cash flow generation support continued shareholder value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
